JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Case Report
A case of malignant melanoma presented with lombar vertebra fracture
Malignant melanoma is a type of skin cancer with a very poor prognosis. It is the most common skin cancer. Metastases are frequently observed in malignant melanoma, which can have a very aggressive course, even without skin findings. Here, we aimed to report a malignant melanoma case presenting with lumbar vertebra fracture, which is a unique form of presentation. A 31-year-old male patient was admitted to the internal medicine outpatient clinic with complaints of low back pain and inability to walk 15 days ago. After the first hour sedimentation value was found to be 101 in the examinations of the patient who came with the complaint of low back pain, he was referred to the hematology department with the preliminary diagnosis of multiple myeloma. Bone marrow aspiration and biopsy was performed. Non-hematopoietic cells were observed in bone marrow aspiration. L2 vertebra fracture was detected in lumbar MRI of the patient with bilateral limitation of movement in the lower extremities. The patient with L2 vertebral fracture was transferred to the neurosurgery service for operation. The patient was diagnosed with malignant melanoma after the frozen biopsy sent after the operation and the previous bone marrow biopsy. Bone marrow infiltration can be seen in malignant melanoma patients. However, a malignant melanoma patient presented with lombar vertebra fracture has not been reported before in the literature.


1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin.2019;69(1):7-34. doi:10.3322/caac.21551
2. Karimkhani C, Green AC, Nijsten T, et al. The global burden ofmelanoma: results from the Global Burden of Disease Study 2015. Br JDermatol. 2017;177(1):134-140. doi:10.1111/bjd.15510
3. Paulson KG, Gupta D, Kim TS, et al. Age-Specific Incidence ofMelanoma in the United States. JAMA Dermatol. 2020;156(1):57-64.doi:10.1001/jamadermatol.2019.33534.
4. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging:Evidence-based changes in the American Joint Committee on Cancereighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472-492. doi:10.3322/caac.21409
5. Rubinstein MA. Malignant melanoma diagnosed by marrow aspiration.Acta Haematologica. 1949;2(4):234-237.
6. Basu D, Bhade BA, Ghotekar LH, Mathew T, Dutta TK. Malignantmelanoma metastatic to bone marrow. Indian J Pathol Microbiol.2002;45(1):107-109.
7. Velasco-Rodríguez D, Castellanos-González M, Alonso-DomínguezJM, Martín-González M, Villarrubia J. Metastatic malignant melanomadetected on bone marrow aspiration. Br J Haematol. 2013;162(4):432.doi:10.1111/bjh.12437
8. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocyticlesions: risk markers or precursors of cutaneous melanoma?. J Am AcadDermatol. 1995;33(6):1000-1007. doi:10.1016/0190-9622(95)90294-5
9. Savage RA, Lucas FV, Hoffman GC. Melanoma in marrow aspirates.Am J Clin Pathol. 1983;79(2):268-269. doi:10.1093/ajcp/79.2.268
Volume 1, Issue 1, 2023
Page : 12-14
_Footer